TransMedics (TMDX) Market Capitalization (2019 - 2026)

TransMedics has reported Market Capitalization for 8 years, with the latest figure at $2.3 billion in Q2 2026.

• On a quarterly basis, Market Capitalization fell 49.58% year-over-year to $2.3 billion in Q2 2026; TTM through Jun 2026 was $2.3 billion, a 49.58% decrease from a year earlier, with the FY2025 full-year figure at $4.2 billion, up 98.88% from the prior year.
• Market Capitalization was $2.3 billion for Q2 2026 at TransMedics, down from $3.4 billion in the prior quarter.
• The five-year high for Market Capitalization was $5.3 billion in Q3 2024, with the low at $753.5 million in Q1 2022.
• Average Market Capitalization over 5 years is $2.8 billion, with a median of $2.4 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Market Capitalization soared 272.55% in 2022, then plunged 49.58% in 2026.
• Over 5 years, Market Capitalization stood at $2.0 billion in 2022, then grew by 29.99% to $2.6 billion in 2023, then decreased by 18.72% to $2.1 billion in 2024, then soared by 98.88% to $4.2 billion in 2025, then sank by 44.82% to $2.3 billion in 2026.
• The last three Market Capitalization figures came in at $2.3 billion (Q2 2026), $3.4 billion (Q1 2026), and $4.2 billion (Q4 2025), per Business Quant data.